These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line. Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900 [TBL] [Abstract][Full Text] [Related]
11. The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway. Greco E; Aita A; Galozzi P; Gava A; Sfriso P; Negm OH; Tighe P; Caso F; Navaglia F; Dazzo E; De Bortoli M; Rampazzo A; Obici L; Donadei S; Merlini G; Plebani M; Todd I; Basso D; Punzi L Arthritis Res Ther; 2015 Apr; 17(1):93. PubMed ID: 25888769 [TBL] [Abstract][Full Text] [Related]
12. Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS). Bachetti T; Chiesa S; Castagnola P; Bani D; Di Zanni E; Omenetti A; D'Osualdo A; Fraldi A; Ballabio A; Ravazzolo R; Martini A; Gattorno M; Ceccherini I Ann Rheum Dis; 2013 Jun; 72(6):1044-52. PubMed ID: 23117241 [TBL] [Abstract][Full Text] [Related]
13. TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS. Rittore C; Méchin D; Sanchez E; Marinèche L; Ea V; Soler S; Vereecke M; Mallavialle A; Richard E; Duroux-Richard I; Apparailly F; Touitou I; Grandemange S Sci Rep; 2021 Feb; 11(1):4172. PubMed ID: 33603056 [TBL] [Abstract][Full Text] [Related]
14. A signalome screening approach in the autoinflammatory disease TNF receptor associated periodic syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing. Todd I; Negm OH; Reps J; Radford P; Figueredo G; McDermott EM; Drewe E; Powell RJ; Bainbridge S; Hamed M; Crouch S; Garibaldi J; St-Gallay S; Fairclough LC; Tighe PJ Pharmacol Res; 2017 Nov; 125(Pt B):188-200. PubMed ID: 28860008 [TBL] [Abstract][Full Text] [Related]
15. Blockade of TNF receptor superfamily 1 (TNFR1)-dependent and TNFR1-independent cell death is crucial for normal epidermal differentiation. Piao X; Miura R; Miyake S; Komazawa-Sakon S; Koike M; Shindo R; Takeda J; Hasegawa A; Abe R; Nishiyama C; Mikami T; Yagita H; Uchiyama Y; Nakano H J Allergy Clin Immunol; 2019 Jan; 143(1):213-228.e10. PubMed ID: 29596938 [TBL] [Abstract][Full Text] [Related]
16. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene. Borghini S; Fiore M; Di Duca M; Caroli F; Finetti M; Santamaria G; Ferlito F; Bua F; Picco P; Obici L; Martini A; Gattorno M; Ceccherini I J Rheumatol; 2011 Jul; 38(7):1378-84. PubMed ID: 21459945 [TBL] [Abstract][Full Text] [Related]
17. Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives. Cudrici C; Deuitch N; Aksentijevich I Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380704 [TBL] [Abstract][Full Text] [Related]